Literature DB >> 9546467

Prognosis in Perthes' disease: a comparison of radiological predictors.

A M Ismail1, M F Macnicol.   

Abstract

We compared the prognostic value of the Catterall grouping, the Salter-Thompson grading, the arthrographic shape of the femoral head, and the Herring lateral pillar grouping during the fragmentation stage of Perthes' disease in 73 patients with 81 affected hips. Radiographs were available for study from the onset of the disease until skeletal maturity. We used the Stulberg classification to assess outcome. The Herring grade and arthrographic sphericity proved to be the best predictors of final outcome. Combining these two values further increased the predictive value. All but one patient in Herring group A achieved an excellent outcome. In Herring group B, the age of the child and the sphericity of the femoral head influenced the end result. If the child was less than seven years old at the onset of symptoms the prognosis was invariably good and all spherical hips in group B had a good outcome with Stulberg grades 1 or 2. Moderately and severely deformed hips on arthrography resulted in Stulberg 3 and 4 hips. None of the hips in Herring group C had a normal appearance at maturity and the outcome was not significantly influenced by the age at onset or the arthrographic appearance.

Entities:  

Mesh:

Year:  1998        PMID: 9546467     DOI: 10.1302/0301-620x.80b2.8054

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  11 in total

1.  Reliability and stability of three common classifications for Legg-Calvé-Perthes disease.

Authors:  Moon Seok Park; Chin Youb Chung; Kyoung Min Lee; Tae Won Kim; Ki Hyuk Sung
Journal:  Clin Orthop Relat Res       Date:  2012-09       Impact factor: 4.176

2.  Varus-producing osteotomy for patients with lateral pillar type B and C Legg-Calvé-Perthes disease followed to skeletal maturity.

Authors:  Pablo Castañeda; Richard Haynes; Jorge Mijares; Héctor Quevedo; Nelson Cassis
Journal:  J Child Orthop       Date:  2008-09-02       Impact factor: 1.548

3.  Timing of premature physeal closure in Legg-Calve-Perthes Disease.

Authors:  Kwang-Won Park; Chastity Amor Rejuso; Won-Tae Cho; Hae-Ryong Song
Journal:  Int Orthop       Date:  2014-06-12       Impact factor: 3.075

Review 4.  Perthes disease: current principles of diagnosis and treatment.

Authors:  Manfred Nelitz; Sabine Lippacher; Rüdiger Krauspe; Heiko Reichel
Journal:  Dtsch Arztebl Int       Date:  2009-08-03       Impact factor: 5.594

5.  Outcome of late-onset Perthes' disease using four different treatment modalities.

Authors:  M K Osman; D J Martin; D A Sherlock
Journal:  J Child Orthop       Date:  2009-05-05       Impact factor: 1.548

6.  Treatment of severe late-onset Perthes' disease with soft tissue release and articulated hip distraction: revisited at skeletal maturity.

Authors:  Eitan Segev; Eli Ezra; Shlomo Wientroub; Moshe Yaniv; Shlomo Hayek; Yoram Hemo
Journal:  J Child Orthop       Date:  2007-09-27       Impact factor: 1.548

7.  The natural history of Perthes' disease.

Authors:  Terje Terjesen; Ola Wiig; Svein Svenningsen
Journal:  Acta Orthop       Date:  2010-11-11       Impact factor: 3.717

8.  Radiographic classifications in Perthes disease.

Authors:  Stefan Huhnstock; Svein Svenningsen; Else Merckoll; Anthony Catterall; Terje Terjesen; Ola Wiig
Journal:  Acta Orthop       Date:  2017-06-14       Impact factor: 3.717

9.  Intra and interobserver concordance between the different classifications used in Legg-Calvé-Perthes disease.

Authors:  André Cicone Liggieri; Marcos Josei Tamanaha; José Jorge Kitagaki Abechain; Tiago Moreno Ikeda; Eiffel Tsuyoshi Dobashi
Journal:  Rev Bras Ortop       Date:  2015-10-23

10.  Effect of greater trochanteric epiphysiodesis after femoral varus osteotomy for lateral pillar classification B and B/C border Legg-Calvé-Perthes disease: A retrospective observational study.

Authors:  Keun-Sang Kwon; Sung Il Wang; Ju-Hyung Lee; Young Jae Moon; Jung Ryul Kim
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.